https://www.selleckchem.com/pr....oducts/sumatriptan.h
able symptomatic, HRQoL, and economic burden. Symptoms persisted and HRQoL worsened despite intravesical BCG treatment. NMIBC is a costly disease, with higher healthcare costs associated with increased risk of disease progression and recurrence. There is a high unmet need for safe and effective treatments that reduce the risk of disease progression and recurrence, provide symptomatic relief, and improve HRQoL for patients. The present study assessed risk factors and patient outcomes of bloodstream infection (BSI) caused by extended-
Like
Comment
Share
